437 related articles for article (PubMed ID: 30635297)
1. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
[TBL] [Abstract][Full Text] [Related]
2. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
3. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
4. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
[TBL] [Abstract][Full Text] [Related]
5. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Zhang D; Adegunsoye A; Oldham JM; Kozlitina J; Garcia N; Poonawalla M; Strykowski R; Linderholm AL; Ley B; Ma SF; Noth I; Strek ME; Wolters PJ; Garcia CK; Newton CA
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37591536
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
8.
Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
11. Influence of MUC5B gene on antisynthetase syndrome.
López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
[TBL] [Abstract][Full Text] [Related]
12. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
13. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
[TBL] [Abstract][Full Text] [Related]
14. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
Transpl Int; 2022; 35():10159. PubMed ID: 35651878
[TBL] [Abstract][Full Text] [Related]
15. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
McDermott G; Gill R; Gagne S; Byrne S; Huang W; Cui J; Prisco L; Zaccardelli A; Martin L; Kronzer VL; Moll M; Cho MH; Shadick N; Dellaripa PF; Doyle T; Sparks JA
Rheumatology (Oxford); 2022 Nov; 61(12):4915-4923. PubMed ID: 35289841
[TBL] [Abstract][Full Text] [Related]
16. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
[TBL] [Abstract][Full Text] [Related]
17. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
18. Identification and Prognosis of Patients With Interstitial Pneumonia With Autoimmune Features.
Jiwrajka N; Loizidis G; Patterson KC; Kreider ME; Johnson CR; Miller WT; Barbosa EJM; Patel N; Beers MF; Litzky LA; George MD; Porteous MK
J Clin Rheumatol; 2022 Aug; 28(5):257-264. PubMed ID: 35697042
[TBL] [Abstract][Full Text] [Related]
19.
Kim JS; Manichaikul AW; Hoffman EA; Balte P; Anderson MR; Bernstein EJ; Madahar P; Oelsner EC; Kawut SM; Wysoczanski A; Laine AF; Adegunsoye A; Ma JZ; Taub MA; Mathias RA; Rich SS; Rotter JI; Noth I; Garcia CK; Barr RG; Podolanczuk AJ
Thorax; 2023 Jun; 78(6):566-573. PubMed ID: 36690926
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
Lee MG; Lee YH
Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
